<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01671878</url>
  </required_header>
  <id_info>
    <org_study_id>GIl1244</org_study_id>
    <nct_id>NCT01671878</nct_id>
  </id_info>
  <brief_title>Glucose and Insulin Responses to Test Foods</brief_title>
  <official_title>Characterization of the Postprandial Glucose and Insulin Responses to Test Foods in Lean and Overweight Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mondelēz International, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Glycemic Index Laboratories, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mondelēz International, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, postprandial glucose and insulin responses of different foods will be measured
      in individuals with varying body weight.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial Glucose Response</measure>
    <time_frame>3 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial Insulin Response</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Glucose Response</condition>
  <condition>Insulin Response</condition>
  <arm_group>
    <arm_group_label>Reference Glucose</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Glucose standard</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Food 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cereal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Food 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biscuit</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Reference Glucose</intervention_name>
    <arm_group_label>Reference Glucose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test Food 1 (Cereal)</intervention_name>
    <arm_group_label>Test Food 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test Food 2 (Biscuit)</intervention_name>
    <arm_group_label>Test Food 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants will be non-smoking males or non-pregnant females aged 20-45y, with
             normal glycemia and in good health. A total of 12 participants will be included, where
             approximately half will be male &amp; half female, and half normal weight (BMI &gt; 19.0 and
             &lt; 25.0) and half overweight but not obese (BMI &gt; 25.0 and &lt; 30). Thus, no fewer than 5
             male, 5 female, 5 normal weight and 5 overweight but not obese subjects will be
             included. Additional inclusion criteria will include:

          -  Absence of diabetes, impaired glucose tolerance and impaired fasting glucose, defined
             as having a fasting plasma glucose &lt; 5.6 mmol/L (100 mg/dL) AND plasma glucose levels
             &lt; 7.8 mmol/L (140 mg/dL) 2h after consumption of a 50 g glucose drink (OGTT will be
             administered during the screening visit)

          -  Systolic blood pressure 100-150 mmHg inclusive

          -  Diastolic blood pressure 60-90 mmHg inclusive

          -  Resting heart rate 50-90 beats/min inclusive after 3 minute rest

          -  Able to refrain from eating legumes and drinking alcohol the day before each test
             session

          -  Fasting triglycerides &lt; 2.0 mmol/L (178 mg/dL)

          -  Fasting HDL cholesterol &gt; 0.9 mmol/L (35 mg/dL) for males and &gt; 1.1mmol/L (42 mg/dL)
             for females

          -  Fasting LDL cholesterol &lt; 5.0 mmol/L (193 mg/dL)

          -  AST and ALT &lt; 120% of upper limit of normal (ULN)

          -  hsCRP &lt; 10 mg/L

          -  Urea and creatinine &lt; 150% ULN

        Exclusion Criteria:

          -  failure to meet any one of the inclusion criteria

          -  age less than 18 or over 45 years

          -  known history or AIDS, hepatitis, diabetes or a heart condition

          -  participants using medications or with any condition which might, in the opinion of
             Dr. Wolever, the president of GI Testing, either: 1) make participation dangerous to
             the subject or to others, or 2) affect the results

          -  participants who cannot or will not comply with the experimental procedures or do not
             follow GI Labs safety guidelines.

          -  Food allergies of any kind

          -  General anaesthesia in the month prior to inclusion.

          -  Smokers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Wolever, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glycemic Index Laboratories, Inc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Glycemic Index Laboratories</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 2N8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2012</study_first_submitted>
  <study_first_submitted_qc>August 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2012</study_first_posted>
  <last_update_submitted>May 6, 2013</last_update_submitted>
  <last_update_submitted_qc>May 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

